Zoetis (ZTS) Asset Writedowns and Impairment (2012 - 2026)

Zoetis (ZTS) has 15 years of Asset Writedowns and Impairment data on file, last reported at $13.0 million in Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment rose 550.0% year-over-year to $13.0 million in Q1 2026; TTM through Mar 2026 was $64.0 million, a 128.57% increase from a year earlier, with the FY2025 full-year figure at $68.0 million, down 29.9% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $13.0 million, down from $29.0 million in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for ZTS reached as high as $88.0 million in Q4 2023 and fell as low as $1.0 million in Q1 2022.
• Historically, Asset Writedowns and Impairment has averaged $19.4 million across 5 years, with a median of $16.0 million in 2023.
• Across the five-year window, Asset Writedowns and Impairment soared 2100.0% in 2023 and plunged 88.24% in 2025, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $4.0 million in 2022, then surged by 2100.0% to $88.0 million in 2023, then sank by 70.45% to $26.0 million in 2024, then grew by 11.54% to $29.0 million in 2025, then sank by 55.17% to $13.0 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $13.0 million in Q1 2026, $29.0 million in Q4 2025, and $22.0 million in Q2 2025.